.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Chubb
UBS
McKinsey
Accenture
Farmers Insurance
Medtronic
Boehringer Ingelheim
Teva

Generated: December 14, 2017

DrugPatentWatch Database Preview

HUMALOG MIX 75/25 Drug Profile

« Back to Dashboard

Which patents cover Humalog Mix 75/25, and when can generic versions of Humalog Mix 75/25 launch?

Humalog Mix 75/25 is a drug marketed by Lilly and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in HUMALOG MIX 75/25 is insulin lispro protamine recombinant; insulin lispro recombinant. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.

Summary for HUMALOG MIX 75/25

Drug patent expirations by year for HUMALOG MIX 75/25

Pharmacology for HUMALOG MIX 75/25

Ingredient-typeInsulin
Drug ClassInsulin Analog

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LillyHUMALOG MIX 75/25insulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-001Dec 22, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
LillyHUMALOG MIX 75/25 KWIKPENinsulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-002Sep 6, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
LillyHUMALOG MIX 75/25 PENinsulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-003Dec 22, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HUMALOG MIX 75/25

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
LillyHUMALOG MIX 75/25insulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-001Dec 22, 1999► Subscribe► Subscribe
LillyHUMALOG MIX 75/25insulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-001Dec 22, 1999► Subscribe► Subscribe
LillyHUMALOG MIX 75/25insulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-001Dec 22, 1999► Subscribe► Subscribe
LillyHUMALOG MIX 75/25insulin lispro protamine recombinant; insulin lispro recombinantINJECTABLE;INJECTION021017-001Dec 22, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Fuji
Boehringer Ingelheim
Novartis
Covington
Cerilliant
Baxter
US Army
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot